Correlation Between Scpharmaceuticals and Forte Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and Forte Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and Forte Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and Forte Biosciences, you can compare the effects of market volatilities on Scpharmaceuticals and Forte Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of Forte Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and Forte Biosciences.

Diversification Opportunities for Scpharmaceuticals and Forte Biosciences

0.03
  Correlation Coefficient

Significant diversification

The 3 months correlation between Scpharmaceuticals and Forte is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and Forte Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Forte Biosciences and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with Forte Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Forte Biosciences has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and Forte Biosciences go up and down completely randomly.

Pair Corralation between Scpharmaceuticals and Forte Biosciences

Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the Forte Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 2.5 times less risky than Forte Biosciences. The stock trades about -0.06 of its potential returns per unit of risk. The Forte Biosciences is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  1,713  in Forte Biosciences on August 25, 2024 and sell it today you would lose (113.00) from holding Forte Biosciences or give up 6.6% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Scpharmaceuticals  vs.  Forte Biosciences

 Performance 
       Timeline  
Scpharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scpharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
Forte Biosciences 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Forte Biosciences are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Forte Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Scpharmaceuticals and Forte Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Scpharmaceuticals and Forte Biosciences

The main advantage of trading using opposite Scpharmaceuticals and Forte Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, Forte Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Forte Biosciences will offset losses from the drop in Forte Biosciences' long position.
The idea behind Scpharmaceuticals and Forte Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences